70 related articles for article (PubMed ID: 26153052)
1. [Association between Proposed Cancer Foci from the Results of Systematic 12-Core Transrectal Needle Biopsies and Actual Cancer Foci from Radical Prostatectomy Specimens].
Takeuchi Y; Sekido N; Kinno K; Sawada Y; Kuroda K; Oharaseki T
Hinyokika Kiyo; 2015 Jun; 61(6):235-9. PubMed ID: 26153052
[TBL] [Abstract][Full Text] [Related]
2. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy.
Borirakchanyavat S; Bhargava V; Shinohara K; Toke A; Carroll PR; Presti JC
Urology; 1997 Sep; 50(3):373-8. PubMed ID: 9301700
[TBL] [Abstract][Full Text] [Related]
3. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer.
Konyalioglu E; Tarhan H; Cakmak O; Pala EE; Zorlu F
Int Braz J Urol; 2015; 41(3):442-8. PubMed ID: 26200537
[TBL] [Abstract][Full Text] [Related]
5. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
Tarján M; Tot T
Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
[TBL] [Abstract][Full Text] [Related]
6. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
7. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract][Full Text] [Related]
8. Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens.
Iremashvili V; Pelaez L; Jorda M; Manoharan M; Arianayagam M; Rosenberg DL; Soloway MS
Urology; 2012 Jan; 79(1):37-42. PubMed ID: 22055691
[TBL] [Abstract][Full Text] [Related]
9. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
11. Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsy.
De Laet K; de la Taille A; Ploussard G; Hoznek A; Vordos D; Yiou R; Allory Y; Azoulay S; Abbou C; Salomon L
BJU Int; 2009 Sep; 104(5):616-20. PubMed ID: 19466953
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population.
Steiner H; Moser P; Hager M; Berger AP; Klocker H; Spranger R; Rogatsch H; Bartsch G; Horninger W
Prostate; 2004 Feb; 58(3):277-82. PubMed ID: 14743467
[TBL] [Abstract][Full Text] [Related]
13. Correlation of transrectal ultrasonography and core biopsies with pathology results in radical prostatectomy specimens.
Türkeri L; Tarcan T; Biren T; Küllü S; Akdaş A
Int J Urol; 1996 Nov; 3(6):459-61. PubMed ID: 9170573
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
[TBL] [Abstract][Full Text] [Related]
15. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
Karram S; Trock BJ; Netto GJ; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
Javali TD; Dwivedi DK; Kumar R; Jagannathan NR; Thulkar S; Dinda AK
Int J Urol; 2014 Mar; 21(3):257-62. PubMed ID: 23980749
[TBL] [Abstract][Full Text] [Related]
17. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?
Kitajima K; Takahashi S; Ueno Y; Miyake H; Fujisawa M; Kawakami F; Sugimura K
Eur J Radiol; 2013 Aug; 82(8):1219-26. PubMed ID: 23518144
[TBL] [Abstract][Full Text] [Related]
18. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
20. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
